annual CFF:
-$218.80M+$206.80M(+48.59%)Summary
- As of today (May 29, 2025), BIO annual cash flow from financing activities is -$218.80 million, with the most recent change of +$206.80 million (+48.59%) on December 31, 2024.
- During the last 3 years, BIO annual CFF has fallen by -$163.37 million (-294.74%).
- BIO annual CFF is now -122.47% below its all-time high of $973.60 million, reached on December 31, 2022.
Performance
BIO Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
-$97.70M-$71.45M(-272.22%)Summary
- As of today (May 29, 2025), BIO quarterly cash flow from financing activities is -$97.70 million, with the most recent change of -$71.45 million (-272.22%) on March 31, 2025.
- Over the past year, BIO quarterly CFF has dropped by -$97.70 million (-100.00%).
- BIO quarterly CFF is now -108.21% below its all-time high of $1.19 billion, reached on March 31, 2022.
Performance
BIO quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$316.50M-$97.70M(-44.65%)Summary
- As of today (May 29, 2025), BIO TTM cash flow from financing activities is -$316.50 million, with the most recent change of -$97.70 million (-44.65%) on March 31, 2025.
- Over the past year, BIO TTM CFF has increased by +$113.41 million (+26.38%).
- BIO TTM CFF is now -126.77% below its all-time high of $1.18 billion, reached on March 31, 2022.
Performance
BIO TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
BIO Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +48.6% | -100.0% | +26.4% |
| 3 y3 years | -294.7% | -108.2% | -126.8% |
| 5 y5 years | -861.4% | +0.9% | -156.2% |
BIO Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -122.5% | +48.6% | -108.2% | +51.8% | -126.8% | +26.4% |
| 5 y | 5-year | -122.5% | +58.2% | -108.2% | +76.8% | -126.8% | +39.5% |
| alltime | all time | -122.5% | +58.2% | -108.2% | +76.8% | -126.8% | +39.5% |
BIO Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$97.70M(+272.2%) | -$316.50M(+44.7%) |
| Dec 2024 | -$218.80M(-48.6%) | -$26.25M(-72.7%) | -$218.80M(-44.3%) |
| Sep 2024 | - | -$95.99M(-0.6%) | -$393.13M(+21.4%) |
| Jun 2024 | - | -$96.57M(<-9900.0%) | -$323.74M(-24.7%) |
| Mar 2024 | - | $0.00(-100.0%) | -$429.91M(+1.0%) |
| Dec 2023 | -$425.60M(-143.7%) | -$200.57M(+654.1%) | -$425.60M(+36.6%) |
| Sep 2023 | - | -$26.60M(-86.9%) | -$311.62M(+6.1%) |
| Jun 2023 | - | -$202.74M(-4805.0%) | -$293.80M(+38.3%) |
| Mar 2023 | - | $4.31M(-105.0%) | -$212.38M(-121.8%) |
| Dec 2022 | $973.60M(-1856.5%) | -$86.59M(+887.2%) | $973.60M(-8.6%) |
| Sep 2022 | - | -$8.77M(-92.8%) | $1.06B(+0.6%) |
| Jun 2022 | - | -$121.33M(-110.2%) | $1.06B(-10.5%) |
| Mar 2022 | - | $1.19B(>+9900.0%) | $1.18B(-2232.8%) |
| Dec 2021 | -$55.43M(-89.4%) | $4.63M(-129.7%) | -$55.43M(-88.5%) |
| Sep 2021 | - | -$15.58M(-643.9%) | -$481.95M(+3.4%) |
| Jun 2021 | - | $2.87M(-106.1%) | -$465.93M(-1.2%) |
| Mar 2021 | - | -$47.35M(-88.8%) | -$471.77M(-9.8%) |
| Dec 2020 | -$523.04M(+2198.3%) | -$421.88M(<-9900.0%) | -$523.04M(+393.7%) |
| Sep 2020 | - | $439.00K(-114.7%) | -$105.94M(-4.4%) |
| Jun 2020 | - | -$2.98M(-97.0%) | -$110.87M(-10.3%) |
| Mar 2020 | - | -$98.62M(+1961.8%) | -$123.54M(+442.8%) |
| Dec 2019 | -$22.76M(-53.2%) | -$4.78M(+6.5%) | -$22.76M(-65.0%) |
| Sep 2019 | - | -$4.49M(-71.3%) | -$64.98M(+3.7%) |
| Jun 2019 | - | -$15.64M(-824.0%) | -$62.66M(+27.8%) |
| Mar 2019 | - | $2.16M(-104.6%) | -$49.03M(+0.7%) |
| Dec 2018 | -$48.68M(<-9900.0%) | -$47.00M(+2060.1%) | -$48.68M(-2663.5%) |
| Sep 2018 | - | -$2.18M(+7.9%) | $1.90M(+53.8%) |
| Jun 2018 | - | -$2.02M(-180.2%) | $1.24M(-43.4%) |
| Mar 2018 | - | $2.52M(-29.7%) | $2.18M(+540.2%) |
| Dec 2017 | $341.00K(-96.2%) | $3.58M(-225.9%) | $341.00K(-184.0%) |
| Sep 2017 | - | -$2.84M(+165.9%) | -$406.00K(-107.6%) |
| Jun 2017 | - | -$1.07M(-258.7%) | $5.33M(-43.5%) |
| Mar 2017 | - | $673.00K(-76.2%) | $9.44M(+4.6%) |
| Dec 2016 | $9.02M(+5.1%) | $2.83M(-2.3%) | $9.02M(-9.1%) |
| Sep 2016 | - | $2.90M(-4.6%) | $9.92M(+8.5%) |
| Jun 2016 | - | $3.04M(+1076.7%) | $9.14M(-0.3%) |
| Mar 2016 | - | $258.00K(-93.1%) | $9.17M(+6.9%) |
| Dec 2015 | $8.58M(-26.6%) | $3.73M(+75.6%) | $8.58M(+1.2%) |
| Sep 2015 | - | $2.12M(-30.6%) | $8.48M(+4.4%) |
| Jun 2015 | - | $3.06M(-1024.8%) | $8.12M(+3.2%) |
| Mar 2015 | - | -$331.00K(-109.1%) | $7.87M(-32.7%) |
| Dec 2014 | $11.69M(-103.8%) | $3.63M(+105.3%) | $11.69M(-1.2%) |
| Sep 2014 | - | $1.77M(-37.1%) | $11.83M(-104.0%) |
| Jun 2014 | - | $2.81M(-19.5%) | -$299.26M(-0.5%) |
| Mar 2014 | - | $3.49M(-7.4%) | -$300.78M(-3.5%) |
| Dec 2013 | -$311.70M(-2576.1%) | $3.77M(-101.2%) | -$311.70M(-0.1%) |
| Sep 2013 | - | -$309.33M(<-9900.0%) | -$311.95M(>+9900.0%) |
| Jun 2013 | - | $1.29M(-117.4%) | -$67.00K(-104.6%) |
| Mar 2013 | - | -$7.43M(-311.3%) | $1.44M(-88.5%) |
| Dec 2012 | $12.59M(-105.9%) | $3.52M(+37.6%) | $12.59M(+71.5%) |
| Sep 2012 | - | $2.55M(-8.8%) | $7.34M(+7.3%) |
| Jun 2012 | - | $2.80M(-24.7%) | $6.84M(+39.6%) |
| Mar 2012 | - | $3.72M(-314.6%) | $4.90M(-102.3%) |
| Dec 2011 | -$213.56M(-193.4%) | -$1.73M(-184.3%) | -$213.56M(-2302.8%) |
| Sep 2011 | - | $2.06M(+139.1%) | $9.70M(-9.1%) |
| Jun 2011 | - | $860.00K(-100.4%) | $10.67M(-17.7%) |
| Mar 2011 | - | -$214.74M(-196.9%) | $12.97M(-94.3%) |
| Dec 2010 | $228.75M(-22.2%) | $221.52M(+7206.1%) | $228.75M(+2472.2%) |
| Sep 2010 | - | $3.03M(-4.0%) | $8.89M(+26.7%) |
| Jun 2010 | - | $3.16M(+205.7%) | $7.02M(-97.6%) |
| Mar 2010 | - | $1.03M(-38.1%) | $297.01M(+1.0%) |
| Dec 2009 | $293.93M(+4542.8%) | $1.67M(+44.2%) | $293.93M(-0.1%) |
| Sep 2009 | - | $1.16M(-99.6%) | $294.19M(+0.1%) |
| Jun 2009 | - | $293.15M(<-9900.0%) | $293.76M(>+9900.0%) |
| Mar 2009 | - | -$2.04M(-206.3%) | $1.50M(-76.3%) |
| Dec 2008 | $6.33M(-185.0%) | $1.92M(+162.2%) | $6.33M(-140.5%) |
| Sep 2008 | - | $733.00K(-17.4%) | -$15.63M(+19.1%) |
| Jun 2008 | - | $887.00K(-68.2%) | -$13.13M(+10.1%) |
| Mar 2008 | - | $2.79M(-113.9%) | -$11.93M(+60.1%) |
| Dec 2007 | -$7.45M | -$20.04M(-719.5%) | -$7.45M(-156.5%) |
| Sep 2007 | - | $3.23M(+54.8%) | $13.19M(+1.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2007 | - | $2.09M(-71.2%) | $12.98M(-11.9%) |
| Mar 2007 | - | $7.26M(+1110.8%) | $14.73M(+45.0%) |
| Dec 2006 | $10.16M(+687.8%) | $600.00K(-80.2%) | $10.16M(+60.1%) |
| Sep 2006 | - | $3.03M(-21.2%) | $6.35M(+132.3%) |
| Jun 2006 | - | $3.84M(+42.4%) | $2.73M(+129.5%) |
| Mar 2006 | - | $2.70M(-183.9%) | $1.19M(-7.7%) |
| Dec 2005 | $1.29M(-99.3%) | -$3.21M(+445.5%) | $1.29M(-99.4%) |
| Sep 2005 | - | -$589.00K(-125.6%) | $204.24M(+4.7%) |
| Jun 2005 | - | $2.30M(-17.8%) | $195.07M(-0.5%) |
| Mar 2005 | - | $2.79M(-98.6%) | $196.05M(+1.5%) |
| Dec 2004 | $193.23M(+78.6%) | $199.73M(-2146.9%) | $193.23M(-3677.6%) |
| Sep 2004 | - | -$9.76M(-397.8%) | -$5.40M(-104.8%) |
| Jun 2004 | - | $3.28M(<-9900.0%) | $112.69M(+1.9%) |
| Mar 2004 | - | -$24.00K(-102.2%) | $110.56M(+2.2%) |
| Dec 2003 | $108.17M(-236.7%) | $1.10M(-99.0%) | $108.17M(+53.4%) |
| Sep 2003 | - | $108.34M(+9403.2%) | $70.52M(-250.3%) |
| Jun 2003 | - | $1.14M(-147.3%) | -$46.90M(-32.5%) |
| Mar 2003 | - | -$2.41M(-93.4%) | -$69.54M(-12.1%) |
| Dec 2002 | -$79.13M(+292.5%) | -$36.55M(+302.3%) | -$79.13M(+42.6%) |
| Sep 2002 | - | -$9.08M(-57.7%) | -$55.49M(+18.4%) |
| Jun 2002 | - | -$21.49M(+79.1%) | -$46.86M(+43.8%) |
| Mar 2002 | - | -$12.00M(-7.0%) | -$32.58M(+61.6%) |
| Dec 2001 | -$20.16M(-51.5%) | -$12.91M(+2750.1%) | -$20.16M(+82.4%) |
| Sep 2001 | - | -$453.00K(-93.7%) | -$11.06M(-76.7%) |
| Jun 2001 | - | -$7.21M(-1838.1%) | -$47.47M(-3.9%) |
| Mar 2001 | - | $415.00K(-110.9%) | -$49.38M(+18.7%) |
| Dec 2000 | -$41.61M(-122.8%) | -$3.81M(-89.7%) | -$41.61M(-126.9%) |
| Sep 2000 | - | -$36.87M(+304.3%) | $154.40M(-16.8%) |
| Jun 2000 | - | -$9.12M(-211.4%) | $185.67M(-3.4%) |
| Mar 2000 | - | $8.19M(-95.7%) | $192.19M(+5.4%) |
| Dec 1999 | $182.30M(<-9900.0%) | $192.20M(-3532.1%) | $182.30M(-1727.7%) |
| Sep 1999 | - | -$5.60M(+115.4%) | -$11.20M(-24.8%) |
| Jun 1999 | - | -$2.60M(+52.9%) | -$14.90M(+50.5%) |
| Mar 1999 | - | -$1.70M(+30.8%) | -$9.90M(+1000.0%) |
| Dec 1998 | -$900.00K(-102.7%) | -$1.30M(-86.0%) | -$900.00K(-102.3%) |
| Sep 1998 | - | -$9.30M(-487.5%) | $39.20M(-16.2%) |
| Jun 1998 | - | $2.40M(-67.1%) | $46.80M(+28.2%) |
| Mar 1998 | - | $7.30M(-81.2%) | $36.50M(+9.0%) |
| Dec 1997 | $33.50M(-232.9%) | $38.80M(-2382.4%) | $33.50M(-238.4%) |
| Sep 1997 | - | -$1.70M(-78.5%) | -$24.20M(+13.1%) |
| Jun 1997 | - | -$7.90M(-283.7%) | -$21.40M(+25.9%) |
| Mar 1997 | - | $4.30M(-122.8%) | -$17.00M(-32.5%) |
| Dec 1996 | -$25.20M(+92.4%) | -$18.90M(-1818.2%) | -$25.20M(+133.3%) |
| Sep 1996 | - | $1.10M(-131.4%) | -$10.80M(-27.0%) |
| Jun 1996 | - | -$3.50M(-10.3%) | -$14.80M(-7.5%) |
| Mar 1996 | - | -$3.90M(-13.3%) | -$16.00M(+22.1%) |
| Dec 1995 | -$13.10M(-60.2%) | -$4.50M(+55.2%) | -$13.10M(-20.6%) |
| Sep 1995 | - | -$2.90M(-38.3%) | -$16.50M(-10.3%) |
| Jun 1995 | - | -$4.70M(+370.0%) | -$18.40M(-25.5%) |
| Mar 1995 | - | -$1.00M(-87.3%) | -$24.70M(-24.9%) |
| Dec 1994 | -$32.90M(+116.4%) | -$7.90M(+64.6%) | -$32.90M(-25.2%) |
| Sep 1994 | - | -$4.80M(-56.4%) | -$44.00M(-0.9%) |
| Jun 1994 | - | -$11.00M(+19.6%) | -$44.40M(+69.5%) |
| Mar 1994 | - | -$9.20M(-51.6%) | -$26.20M(+72.4%) |
| Dec 1993 | -$15.20M(-994.1%) | -$19.00M(+265.4%) | -$15.20M(-235.7%) |
| Sep 1993 | - | -$5.20M(-172.2%) | $11.20M(-1966.7%) |
| Jun 1993 | - | $7.20M(+300.0%) | -$600.00K(-154.5%) |
| Mar 1993 | - | $1.80M(-75.7%) | $1.10M(-35.3%) |
| Dec 1992 | $1.70M(-93.3%) | $7.40M(-143.5%) | $1.70M(-177.3%) |
| Sep 1992 | - | -$17.00M(-291.0%) | -$2.20M(-108.2%) |
| Jun 1992 | - | $8.90M(+270.8%) | $26.80M(+30.7%) |
| Mar 1992 | - | $2.40M(-31.4%) | $20.50M(-19.3%) |
| Dec 1991 | $25.40M(+243.2%) | $3.50M(-70.8%) | $25.40M(-0.4%) |
| Sep 1991 | - | $12.00M(+361.5%) | $25.50M(+96.2%) |
| Jun 1991 | - | $2.60M(-64.4%) | $13.00M(-5.8%) |
| Mar 1991 | - | $7.30M(+102.8%) | $13.80M(+86.5%) |
| Dec 1990 | $7.40M(+23.3%) | $3.60M(-820.0%) | $7.40M(+94.7%) |
| Sep 1990 | - | -$500.00K(-114.7%) | $3.80M(-11.6%) |
| Jun 1990 | - | $3.40M(+277.8%) | $4.30M(+377.8%) |
| Mar 1990 | - | $900.00K | $900.00K |
| Dec 1989 | $6.00M | - | - |
FAQ
- What is Bio-Rad Laboratories annual cash flow from financing activities?
- What is the all time high annual CFF for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories annual CFF year-on-year change?
- What is Bio-Rad Laboratories quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories quarterly CFF year-on-year change?
- What is Bio-Rad Laboratories TTM cash flow from financing activities?
- What is the all time high TTM CFF for Bio-Rad Laboratories?
- What is Bio-Rad Laboratories TTM CFF year-on-year change?
What is Bio-Rad Laboratories annual cash flow from financing activities?
The current annual CFF of BIO is -$218.80M
What is the all time high annual CFF for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high annual cash flow from financing activities is $973.60M
What is Bio-Rad Laboratories annual CFF year-on-year change?
Over the past year, BIO annual cash flow from financing activities has changed by +$206.80M (+48.59%)
What is Bio-Rad Laboratories quarterly cash flow from financing activities?
The current quarterly CFF of BIO is -$97.70M
What is the all time high quarterly CFF for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high quarterly cash flow from financing activities is $1.19B
What is Bio-Rad Laboratories quarterly CFF year-on-year change?
Over the past year, BIO quarterly cash flow from financing activities has changed by -$97.70M (-100.00%)
What is Bio-Rad Laboratories TTM cash flow from financing activities?
The current TTM CFF of BIO is -$316.50M
What is the all time high TTM CFF for Bio-Rad Laboratories?
Bio-Rad Laboratories all-time high TTM cash flow from financing activities is $1.18B
What is Bio-Rad Laboratories TTM CFF year-on-year change?
Over the past year, BIO TTM cash flow from financing activities has changed by +$113.41M (+26.38%)